RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
A method for synthesizing camptothecin and camptothecin analogs
using a novel hydroxyl-containing tricyclic intermediate and the
camptothecin analogs produced by the process. The camptothecin
analogs are effective inhibitors of topoisomerase I and show
anti-leukemic and anti-tumor activity.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.